traumatic subarachnoid hemorrhage

Navigating Dilated Cardiomyopathy: Beyond Standard Care

Dilated cardiomyopathy management focuses on symptom control, preventing disease progression, and reducing adverse cardiac events through guideline-directed medical therapy.

Noninvasive Ventilation: A Shift in End-of-Life Care for ALS?

Noninvasive ventilation may reduce requests for medical assistance in dying (MAiD) among patients with amyotrophic lateral sclerosis (ALS). This suggests a potential impact on end-of-life decisions.

Traditional Chinese Medicines Plus Metformin: An A1c Advantage?

Combining Traditional Chinese Medicines with metformin may offer additional A1c reductions for patients with type 2 diabetes.

Atorvastatin's CV Benefit in Older Adults: More Nonfatal Events Than Deaths?

Atorvastatin reduces major cardiovascular events in older adults, with the benefit primarily driven by a reduction in nonfatal events rather than mortality.

Statins: When to start primary prevention after age 70?

Statins can reduce the risk of first heart attack and stroke by approximately 30% in individuals over 70 years of age.

Bilateral Focused Ultrasound: A New Path for Parkinson's Motor Control?

Staged, bilateral MRgFUS pallidothalamic tractotomy significantly improved motor complications in Parkinson's disease, offering an incisionless alternative to DBS.

Dual-target gene therapy: Can it free Parkinson's patients from levodopa dependence?

A dual-target gene therapy, BBM-P002, demonstrated a favorable safety profile in a Phase 1 trial for moderate-to-advanced Parkinson's disease.

Repatha before PCI for acute MI: Better lipids, but no better outcomes

Pre-PCI Repatha improves lipid profiles in acute MI patients but does not translate into a reduction in major adverse cardiovascular events.

Olorofim shows promise against resistant invasive fungal disease

Olorofim, a novel orotomide antifungal, demonstrated efficacy and safety in a Phase 2b study for invasive fungal diseases with limited treatment options.